These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis. Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340 [TBL] [Abstract][Full Text] [Related]
7. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study. Blinkenberg M; Kjellberg J; Ibsen R; Magyari M Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting. Rahimian N; Saligheh Rad H; Firouznia K; Ebrahimzadeh SA; Meysamie A; Vafaiean H; Harirchian MH Iran J Radiol; 2013 Sep; 10(3):128-32. PubMed ID: 24348597 [TBL] [Abstract][Full Text] [Related]
9. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194 [TBL] [Abstract][Full Text] [Related]